Studies bij diverse tumoren met specifieke moleculaire afwijkingen

Op deze pagina

Planned

There are currently no planned studies in our center.

Ongoing

IMBRELLA-B BO40729

An open label, multicenter extension study in patients previously enrolled in a genentech and/or F. Hoffmann-La Roche LTD sponsored Atezolizumab study (Imbrella B)

Closed

There are currently no closed studies in our center.

Laatste aanpassing: 17 april 2023